Unknown

Dataset Information

0

P53 mutation, deprivation and poor prognosis in primary breast cancer.


ABSTRACT: BACKGROUND: The deprivation gap for breast cancer survival remains unexplained by stage at presentation, treatment, or co-morbidities. We hypothesised that p53 mutation might contribute to the impaired outcome observed in patients from deprived communities. METHODS: p53 mutation status was determined using the Roche Amplichip research test in 246 women with primary breast cancer attending a single cancer centre and related to deprivation, pathology, overall, and disease-free survival. RESULTS: p53 mutation, identified in 64/246 (26%) of cancers, was most common in 10 out of 17 (58.8%) of the lowest (10th) deprivation decile. Those patients with p53 mutation in the 10th decile had a significantly worse disease-free survival of only 20% at 5 years (Kaplan-Meier logrank chi(2)=6.050, P=0.014) and worse overall survival of 24% at 5 years (Kaplan-Meier logrank chi(2)=6.791, P=0.009) than women of deciles 1-9 with p53 mutation (c.f. 56% and 72%, respectively) or patients in the 10th decile with wild-type p53 (no disease relapse or deaths). CONCLUSION: p53 mutation in breast cancer is associated with socio-economic deprivation and may provide a molecular basis, with therapeutic implications, for the poorer outcome in women from deprived communities.

SUBMITTER: Baker L 

PROVIDER: S-EPMC2837559 | biostudies-other | 2010 Feb

REPOSITORIES: biostudies-other

Similar Datasets

| S-EPMC7419805 | biostudies-literature
| S-EPMC8669954 | biostudies-literature
| S-ECPF-SMDB-1443 | biostudies-other
| S-EPMC5126584 | biostudies-literature
| S-EPMC3109573 | biostudies-literature
2005-06-22 | E-SMDB-1443 | biostudies-arrayexpress
| S-EPMC3566821 | biostudies-other
| S-EPMC4705085 | biostudies-literature
2019-10-15 | PXD011253 | Pride
| S-EPMC8018597 | biostudies-literature